High Katherine A has filed 7 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 2518 shares of INCYTE CORP ($INCY) on June 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 10, 2025 | INCYTE CORP | $INCY | High Katherine A | Director | A | Common Stock | 2518 | $0.00 | 13,341.0000 | 210,530,000 | 23.27% | 0.00% |
| June 10, 2025 | INCYTE CORP | $INCY | High Katherine A | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 5, 2025 | CRISPR Therapeutics AG | $CRSP | High Katherine A | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 85,774,474 | 9999.99% | 0.02% |
| June 12, 2024 | INCYTE CORP | $INCY | High Katherine A | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | INCYTE CORP | $INCY | High Katherine A | Director | A | Common Stock | 2830 | $0.00 | 10,823.0000 | 225,928,000 | 35.41% | 0.00% |
| May 30, 2024 | CRISPR Therapeutics AG | $CRSP | High Katherine A | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | CRISPR Therapeutics AG | $CRSP | High Katherine A | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |